Mediclinic International (MDC) Share Forecast, Price & News

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Mediclinic International in the last year. There are currently 2 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" MDC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MDC, but not buy additional shares or sell existing shares.
View MDC analyst ratings or view top-rated stocks.

2 analysts have issued 12 month target prices for Mediclinic International's stock. Their MDC share price forecasts range from GBX 464 to GBX 504. On average, they expect the company's share price to reach GBX 484 in the next twelve months. This suggests that the stock has a possible downside of 3.4%.
View analysts price targets for MDC or view top-rated stocks among Wall Street analysts.

Mediclinic International's stock was trading at GBX 498 at the beginning of the year. Since then, MDC shares have increased by 0.6% and is now trading at GBX 501.
View the best growth stocks for 2023 here.

Mediclinic International (LON:MDC) pays an annual dividend of GBX 3 per share and currently has a dividend yield of 0.60%. The dividend payout ratio is 1,304.35%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for MDC.

Based on aggregate information from My MarketBeat watchlists, some companies that other Mediclinic International investors own include Intu Properties (INTU), Capital & Counties Properties PLC (CAPC), Rdi Reit (RDI), British American Tobacco (BATS), Central Asia Metals (CAML), DRDGOLD (DRD), UK Oil & Gas (UKOG), Spire Healthcare Group (SPI), Premier Oil (PMO) and Ferrexpo (FXPO).

Mediclinic International trades on the London Stock Exchange (LON) under the ticker symbol "MDC."

Shares of MDC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

One share of MDC stock can currently be purchased for approximately GBX 501.

Mediclinic International (LON:MDC) has a market capitalization of £3.69 billion and generates £3.38 billion in revenue each year. The company earns £169 million in net income (profit) each year or GBX 0.23 on an earnings per share basis.

The company employs 30,470 workers across the globe.

Mediclinic International's mailing address is 6th Floor 65 Gresham Street, LONDON, EC2V 7NQ, United Kingdom. The official website for the company is www.mediclinic.com. The company can be reached via phone at +44-20-79549600.